Abstract
Retrospective Observational Study Evaluating Efficacy of Saroglitazar 4mg in Type 2 Diabetic Dyslipidemic Patients at Tertiary Care Centre in India
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have